Evolutionary Genomics Stock

Evolutionary Genomics Debt

The Debt of Evolutionary Genomics (FNAM) as of Aug 11, 2026 is 3.74 M USD. In the previous year, Debt was 3.74 M USD — a change of 0.00% (lower).

Debt

3.74 MUSD

YoY

0.00%

Last updated:

In 2026, Evolutionary Genomics's total debt was 3.74 M USD, a 0.00% change from the 3.74 M USD total debt recorded in the previous year.

Access this data via the Eulerpool API
Get Free API Key

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics is one of the most popular companies on Eulerpool.

Debt Details

Understanding Evolutionary Genomics's Debt Structure

Evolutionary Genomics's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Evolutionary Genomics's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Evolutionary Genomics’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Evolutionary Genomics’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Evolutionary Genomics stock

Debt of Evolutionary Genomics is 3.74 M USD in 2026.

Debt of Evolutionary Genomics changed from 3.74 M USD to 3.74 M USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Evolutionary Genomics historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Evolutionary Genomics

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Evolutionary Genomics